Weighted logrank tests to detect a transient improvement in survivorship

Biometrics

Volumn 53, Issue 2, 1997, Pages 736-744

  Wallenstein, Sylvan ^a   Berger, Agnes ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Gompertz distribution; Hazard function; Lag model; Survival analysis

Indexed keywords

COMPLIANCE CONTROL; CONTINUOUS TIME SYSTEMS; DISTRIBUTION FUNCTIONS; FUNCTION EVALUATION; VIRUSES;

DRUG-RESISTANT VIRUS; FUNCTION OF TIME; GOMPERTZ DISTRIBUTIONS; HAZARD FUNCTION; LAG MODEL; LEVELING OFFS; LIFE STYLES; SURVIVAL ANALYSIS; TRANSIENT IMPROVEMENT; WEIGHT FUNCTIONS;

HAZARDS;

ARTICLE; STATISTICAL ANALYSIS; STATISTICAL MODEL; SURVIVAL;

GOES;

EID: 0030961601     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533974     Document Type: Article

References (25)

1. Aron, J. L. and Prorok, P. C. (1986). An analysis of the mortality effect in a breast cancer screening study. International Journal of Epidemiology 15, 36-43.
2. Berger, A. (1983). On comparing survival probabilities from discrete observations under unequal censoring. Statistics and Probability Letters 1, 251-257.
3. Cantor, A. and Shuster, J. (1992). Parametric versus nonparametric methods for estimating cure rates based on censored survival data. Statistics in Medicine 11, 931-937.
4. Cleveland, W. S. (1981). LOWESS: A procedure for smoothing scatterplots by locally weighted regression. The American Statistician 35, 54.
5. Etzioni, R. and Self, S. G. (1995). On the catch-up method for analyzing cancer screening trials. Biometrics 51, 31-43, correction 1589.
6. Fix, E. and Neyman, J. (1951). A simple stochastic model of recovery, relapse, death and loss of patients. Human Biology 23, 205-241.
7. Fleming, T. R. and Harrington, D. P. (1991). Counting Processes and Survival Data. New York: Wiley.
8. Gehan, E. A. (1965). A generalized Wilcoxon test for comparing arbitrarily right censored samples. Biometrika 52, 202-223.
9. Gray, R. J. and Tsiatis, A. A. (1989). A linear rank test for use when the main interest is in differences in cure rates. Biometrics 45, 899-904.
10. Halperin, M., Rogot, E., Gurian, J., and Ederer, F. (1968). Sample sizes needed for medical trials with special reference to long term therapy. Journal of Chronic Diseases 21, 13-24.
11. Harrington, D. P. and Fleming, T. R. (1982). A class of rank tests for censored survival data. Biometrika 69, 553-566.
12. Kodlin, D. (1967). A new response time distribution. Biometrics 23, 227-239.
13. Lan, K. K. G. and Wittes, J. (1994). Data monitoring in complex clinical trials: Which treatment is 'better'? Journal of Statistical Planning and Inference 42, 241-255.
14. Mantel, N. and Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective study of disease. Journal of the National Cancer Institute 22, 719-748.
15. Neyman, J. (1959). Optimal asymptotic tests of composite statistical hypotheses. In Probability and Statistics, Harald Cramer Volume, Ulf Grenander (ed), 213-234. New York: Wiley.
16. Peto, R. and Peto, J. (1972). Asymptotically efficient rank invariant procedures. Journal of the Royal Statistical Society, Series A 135, 185-206.
17. Schoenfeld, D. (1981). The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 68, 316-319.
18. Self, S., et al. (1988). Statistical design of the Women's Health Trial. Controlled Clinical Trials 9, 119-136.
19. Self, S. G. (1991). An adaptive weighted logrank test with application to cancer prevention and screening trials. Biometrics 47, 975-986.
20. Self, S. G. and Etzioni, R. (1995). A likelihood ratio test for cancer screening trials. Biometrics 51, 44-50.
21. Shapiro, S. (1977). Evidence on screening for breast cancer from a randomized trial. Cancer 39, 2772-2782.
22. SYSTAT. (1992). SYSTAT: Graphics, Version 5.2. Evanston, Illinois: SYSTAT Inc.
23. Tarone, R. and Ware, J. (1977). On distribution free tests for equality of survival distributions. Biometrika 64, 156-160.
24. Volberding, P., Lagakos, S., Grimes, J., Stein, D., Balfour, H., Reichman, R., Bartlett, J., Hirsch, M., Phair, J., Mitsuyasu, R., Fischl, M., and Soeiro, R. (1994). The duration of zidovudine benefit in persons with asymptomatic HIV infection. Journal of the American Medical Association 272, 437-442.
25. Zucker, D. M. and Lakatos, E. (1990). Weighted log rank statistics for comparing survival curves when there is a time lag in the effectiveness of treatment. Biometrika 7, 853-864.